Product Information
VALSARTAN 40 MG TABLET is a generic product labeled by Archis Pharma LLC, priced at $0.0963 per EA under NDC 72819018103. Its NADAC has been published 183 times since Apr 5, 2023.
FDA first approved this application on Apr 9, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the valsartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/1
Manufacturer
Archis Pharma LLCNDC
72819018103
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA205347FDA Approved
4/9/2018
TE Code
AB
On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for VALSARTAN 40 MG TABLET has been published 183 times since Apr 5, 2023, and over the history we have for it it has declined 29.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0963 per EA |
|---|---|
| All-time high | $0.1588 (Aug 16, 2023) |
| All-time low | $0.0960 (Jul 22, 2026) |
| 52-week high | $0.1219 |
| 52-week low | $0.0960 |
| Median price | $0.1281 |
| Average price | $0.1260 |
| Largest weekly change | +45.1% (Aug 21, 2024) |
| Weeks tracked | 183 |
| Tracking since | Apr 5, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Archis Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
valsartan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALSARTAN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN 40 MG TABLET, manufactured by Archis Pharma LLC, is $0.0963 per EA (NDC 72819018103), effective Sep 30, 2026.
How has the price of VALSARTAN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for VALSARTAN 40 MG TABLET has declined 29.6%. It has been tracked across 183 weekly CMS publications since Apr 5, 2023.
What are the highest and lowest recorded NADAC prices for VALSARTAN 40 MG TABLET?
Since Apr 5, 2023, the NADAC for VALSARTAN 40 MG TABLET has ranged from a low of $0.0960 (Jul 22, 2026) to a high of $0.1588 (Aug 16, 2023), with a median of $0.1281 per EA.
Are there cheaper alternatives to VALSARTAN 40 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALSARTAN 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VALSARTAN 40 MG TABLET?
VALSARTAN 40 MG TABLET (NDC 72819018103) is labeled by Archis Pharma LLC, and CMS classifies it as a generic product.